The global iodine market reached a value of US$ 897.2 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1,246.30 Million by 2027, exhibiting a CAGR of 5.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Iodine (I2) is a trace element naturally found in dairy products, seafood, seaweed, eggs, and vegetables. It is widely utilized for making the thyroid hormones thyroxine (T4) and triiodothyronine (T3) as it assists in regulating the metabolism and increasing the production of proteins. Besides this, as it also aids in treating mammary dysplasia and fibrocystic breast disease, the consumption of I2-rich food products is escalating across the globe. Iodine Market Trends: There is presently a rise in the number of people suffering from I2 deficiency disorders, which include mental retardation, hypothyroidism, goiter, cretinism, and varying degrees of other growth and developmental abnormalities. As a result, international health organizations are mandating the use of all food-grade salt in households and food processing units for preventing and controlling I2 deficiency disorders around the world. This, in confluence with the thriving pharmaceutical industry, is bolstering the growth of the market. Moreover, I2 is employed as a disinfectant for cleaning surfaces and storage containers, skin soaps and bandages, and purifying water. It also plays a crucial role as a reagent in analytical chemistry and a catalyst in the alkylation and condensation of aromatic amines and sulfation and sulfonations. Apart from this, I2 is used in the manufacturing of organic and inorganic chemicals, radiopaque contrast agents, animal feed supplements, stabilizers, inks, colorants, photographic chemicals, and synthetic rubber. This, coupled with the rising demand for I2 in X-radiation imaging modalities, such as computed tomography (CT), is strengthening the growth of the market. Other factors, such as the increasing health consciousness among individuals and significant growth in the healthcare industry, are positively influencing the overall sales and profitability.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global iodine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on source, form and application.
Breakup by Source: Underground Brine Caliche Ore Recycling Seaweeds
Breakup by Form: Inorganic Salts and Complexes Organic Compounds Elementals and Isotopes
Breakup by Application: Animal Feed X-Ray Contrast Media Biocides Optical Polarizing Films Fluorochemicals Nylon Others
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Algorta Norte Sa, Calibre Chemicals Pvt. Ltd., Deepwater Chemicals Inc. (Toyota Tsusho Corporation), Eskay Iodine Pvt. Ltd., GODO SHIGEN Co. Ltd., Iochem Corporation, Iofina plc, Ise Chemicals Corporation (AGC Inc.), Nippoh Chemicals Co. Ltd., Protochem Industries Pvt. Ltd., Salvi Chemical Industries Ltd. and Sociedad Quimica y Minera de Chile S.A.
Key Questions Answered in This Report: How has the global iodine market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global iodine market? What are the key regional markets? What is the breakup of the market based on the source? What is the breakup of the market based on the form? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global iodine market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The global injectables market is estimated to reach US$836.6 billion in 2026, progressing at a CAGR of 10.95%, over the period 2022-2026. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The Global Benign Prostatic Hyperplasia Therapeutics Market size is expected to reach $7.4 billion by 2027, rising at a market growth of 4.6% CAGR during the forecast period. Benign prostatic hyperplasia (BPH) is a benign swelling of the prostate gland that is not malignant. Benign prostatic hypertrophy or benign prostatic blockages...
Wearable Injectors Market By Type (On-Body and Off-Body), Usage (Disposable and Semi-Reusable), Technology (Electronic, Mechanical, and Others), Mechanism Of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Disease,...
The global genitourinary drugs market is expected to grow at a CAGR of around 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. The...
Cushing’s Syndrome - Opportunity Assessment and Forecast to 2030 Summary Cushing’s Syndrome is a disorder caused by the body’s exposure to an excess of the hormone cortisol.Cortisol affects all tissues and organs in the body, and collectively these effects are known as CS. This disorder can...
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Drugs in Development, 2021 Summary Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Protein kinase C theta (PKC-?) is an enzyme encoded by the PRKCQ gene. It mediates non-redundant functions in T-cell receptor...
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026. The global IV and oral iron drugs market is expected to grow due to the prevalence...
Healthcare
Pharmaceutical
Therapy
Endocrine Disease
Nutrition
Blood Disease
E-Commerce
Heart Failure
World
Anemia Prevalence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.